Review period expiry for use of 4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
4th January 2025
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO)
- 1 use applied for by Octapharma Pharmazeutika Produktionsgesellschaft m.b.H
|
Reference of the decision (2) |
Date of decision |
Substance name |
Holder of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
|
C(2022) 1506 |
16 March 2022 |
4-(1,1,3,3-Tetra methylbutyl)phenol, ethoxylated (4-tert-OPnEO) EC No: -, CAS No:- |
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H, Oberlaaer Straße 235, A-1100 Vienna, Austria |
REACH/22/5/4 |
As component of a chromatography column regeneration solution during the manufacture of a recombinant-derived Factor VIII |
4 January 2025 |